Avidity Biosciences, Inc. - Common Stock (RNA)

Avidity Biosciences Inc is a biotechnology company focused on developing innovative therapies that leverage its proprietary AOC platform, which stands for antibody-oligonucleotide conjugates

This platform aims to deliver therapeutic oligonucleotides directly to specific cells using antibodies, thereby enhancing the precision and effectiveness of treatments for various diseases, including genetic disorders and cancer. The company's research is centered around improving the delivery and efficacy of RNA-based therapies, with the goal of transforming the treatment landscape for patients through targeted and personalized medicine.